Cobicistat: A case of mislabelled drug-drug interaction risk?

Br J Clin Pharmacol. 2020 May;86(5):834-836. doi: 10.1111/bcp.14262. Epub 2020 Mar 6.
No abstract available

Keywords: HIV/AIDS; cytochrome P450; drug interactions.

Publication types

  • Case Reports
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents* / pharmacology
  • Cobicistat* / pharmacology
  • Darunavir
  • Drug Interactions
  • Drug Labeling
  • HIV Infections* / drug therapy
  • Humans
  • Pharmaceutical Preparations*

Substances

  • Anti-HIV Agents
  • Pharmaceutical Preparations
  • Cobicistat
  • Darunavir